Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Beijing Tong Ren Tang Chinese Medicine Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 20.60%.
BJTRF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.04 Med: 63.73 Max: 116.85
Current: 23.16
During the past 13 years, Beijing Tong Ren Tang Chinese Medicine Co's highest ROC (Joel Greenblatt) % was 116.85%. The lowest was 23.04%. And the median was 63.73%.
BJTRF's ROC (Joel Greenblatt) % is ranked better than 67.69% of 981
companies
in the Drug Manufacturers industry
Industry Median: 11.46
vs BJTRF: 23.16
Beijing Tong Ren Tang Chinese Medicine Co (OTCPK:BJTRF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tong Ren Tang Chinese Medicine Co ROC (Joel Greenblatt) % Chart
Beijing Tong Ren Tang Chinese Medicine Co Annual Data
BJTRF vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tong Ren Tang Chinese Medicine Co ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) % falls into.
Beijing Tong Ren Tang Chinese Medicine Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 20.60% mean?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a ROC (Joel Greenblatt) % of 20.60% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. This is 68% below median its historical median of 63.73. Over the past decade, Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) % has ranged from 23.04 to 116.85. According to the industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #317 out of 981 companies in the Drug Manufacturers industry, placing it in the top 32.3%.
Is Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) % too high?
Beijing Tong Ren Tang Chinese Medicine Co's current ROC (Joel Greenblatt) % of 20.60% is 68% below median its 10-year median of 63.73. Over the past 10 years, this metric has ranged from a low of 23.04 to a high of 116.85. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.46. Beijing Tong Ren Tang Chinese Medicine Co's value of 20.60% is 79.8% above this industry median. Based on the distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #317 out of 981 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #317 out of 981 companies for ROC (Joel Greenblatt) %. This puts Beijing Tong Ren Tang Chinese Medicine Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.46. Beijing Tong Ren Tang Chinese Medicine Co's value of 20.60% is 79.8% above this benchmark. Historically, Beijing Tong Ren Tang Chinese Medicine Co's own ROC (Joel Greenblatt) % has ranged from 23.04 to 116.85 over the past decade. While the company's 10-year median is 63.73 vs. the industry median of 11.46, Beijing Tong Ren Tang Chinese Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.46, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tong Ren Tang Chinese Medicine Co's current ROC (Joel Greenblatt) % of 20.60% is 79.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tong Ren Tang Chinese Medicine Co's current ROC (Joel Greenblatt) % is 20.60%, which is 68% below median its own 10-year median of 63.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a current ROC (Joel Greenblatt) % of 20.60%. The stock's GF Value™ is $0.91, compared to a current price of $0.65 — trading 28.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 20.60%, which is 68% below median its 10-year median of 63.73 and 79.8% above the Drug Manufacturers industry median of 11.46. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (BJTRF), the current ROC (Joel Greenblatt) % is 20.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued.
The current stock price of $0.65 is trading 28.7% below its estimated GF Value™ of $0.91.
Key valuation signals for BJTRF:
ROC (Joel Greenblatt) %: 20.60% (68% below median its 10-year median of 63.73)
GF Value™: $0.91 vs. price of $0.65 (28.7% below fair value)
Industry Position: 79.8% above the Drug Manufacturers median (#317 of 981)
No single metric tells the full story. See the BJTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tong Ren Tang Chinese Medicine Co Business Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
89GF Score
Get the complete analysis for BJTRF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJTRF has been successfully added to your 
